Noveome Biotherapeutics Inc.

Noveome Biotherapeutics Inc. Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Noveome Biotherapeutics Inc., Pharmaceuticals, Pittsburgh, PA.

Noveome Biotherapeutics, Inc., a Pittsburgh-based biopharmaceutical company in clinical-stages focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues.

We are excited to share that our  Chief Medical Officer, Dr. Karin Potoka will be speaking at the NEC Symposium in Chica...
08/28/2025

We are excited to share that our Chief Medical Officer, Dr. Karin Potoka will be speaking at the NEC Symposium in Chicago. Dr. Potoka will share information about the potential benefits of our ST266 in the treatment of NEC.

The NEC Symposium in Chicago, presented by the NEC Society, Cincinnati Children’s, and UNC Children’s, is the world’s largest scientific meeting dedicated to necrotizing enterocolitis (NEC).

’s session on Promising Treatments for NEC will explore promising treatment options for NEC and strategies to build a world without this cruel disease through research and innovation. Cassandra Oliger will open the session by sharing the story of her daughter, Nora, who tragically passed away from NEC.

During this session, you will hear from key leaders in the field:

✔️ Eric Benner, MD, PhD – Duke University School of Medicine
✔️ Gail Besner, MD, FACS, FAAP – Nationwide Children’s Hospital
✔️ David Hackam, MD, PhD – Johns Hopkins Children’s Center
✔️ Karin Potoka, MD, FAAP – Noveome Biotherapeutics, Akron Children’s

Current options to treat and are inadequate - collaboration and dialogue at are crucial to advancing NEC research, education, and advocacy.

The Promising Treatments for NEC session will be moderated by David Russell, JD, Director of Research at Cincinnati Children’s and father of a child who survived NEC in the NICU.

Join us for the NEC Symposium in Chicago, happening September 7–10, 2025: NECsociety.org/NEC-Symposium

We are pleased to announce the completion of our Series E financing round. The funds will be used to support financing o...
04/23/2025

We are pleased to announce the completion of our Series E financing round. The funds will be used to support financing our Clinical Trial in NEC. Necrotizing Enterocolitis (NEC) is a devastating disease, affecting thousands of pre-mature infants, with a 30% mortality rate.

The financing will be primarily used to support the advancement of the Company’s clinical stage program for the treatment of Necrotizing Enterocolitis

Address

Pittsburgh, PA

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+14124029914

Alerts

Be the first to know and let us send you an email when Noveome Biotherapeutics Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Noveome Biotherapeutics Inc.:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram